Distribution of Inflammation, Pre-Malignant Lesions, Incidental Carcinoma in Histologically Confirmed Benign Prostatic Hyperplasia: A Retrospective Analysis

Author： Di Silverio F.   Gentile V.   De Matteis A.   Mariotti G.   Giuseppe V.   Antonio Luigi P.   Sciarra A.  

Publisher： Elsevier

ISSN： 0302-2838

Source： European Urology, Vol.43, Iss.2, 2003-02, pp. : 164-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benign, Premalignant, and Malignant Lesions Encountered in Bariatric Surgery

By Raghavendra Rao S.   Kini Dr.  

JSLS, Journal of the Society of Laparoendoscopic Surgeons, Vol. 16, Iss. 3, 2012-07 ,pp. : 360-372

Society of Laparoendoscopic Surgeons

Access to resources Recommend Favorite

Nocturia and benign prostatic hyperplasia

By Yoshimura K.   Ohara H.   Ichioka K.   Terada N.   Matsui Y.   Terai A.   Arai Y.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 786-790

Elsevier

Access to resources Recommend Favorite

Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway

By Johansen Truls E. Bjerklund   Istad Jan Anders  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 2, 2007-01 ,pp. : 124-131

Informa Healthcare

Access to resources Recommend Favorite

Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia

By Boyle P.   Robertson C.   Manski R.   Padley R.J.   Roehrborn C.G.  

Urology, Vol. 58, Iss. 5, 2001-11 ,pp. : 717-722

Elsevier

Access to resources Recommend Favorite

Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia

By Boyle P.   Robertson C.   Lowe F.   Roehrborn C.  

Urology, Vol. 55, Iss. 4, 2000-04 ,pp. : 533-539

Elsevier

Access to resources Recommend Favorite